IL30741A - Oil-in-water skin care emulsion - Google Patents
Oil-in-water skin care emulsionInfo
- Publication number
- IL30741A IL30741A IL30741A IL3074168A IL30741A IL 30741 A IL30741 A IL 30741A IL 30741 A IL30741 A IL 30741A IL 3074168 A IL3074168 A IL 3074168A IL 30741 A IL30741 A IL 30741A
- Authority
- IL
- Israel
- Prior art keywords
- hydroxybenzoate
- water
- weight
- oil
- composition according
- Prior art date
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 16
- 239000000839 emulsion Substances 0.000 title description 12
- 239000000203 mixture Substances 0.000 claims description 34
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 18
- 229920001184 polypeptide Polymers 0.000 claims description 17
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 17
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 11
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 10
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 10
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 10
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 9
- 229960000458 allantoin Drugs 0.000 claims description 9
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 9
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 9
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 9
- 235000019388 lanolin Nutrition 0.000 claims description 8
- 239000004166 Lanolin Substances 0.000 claims description 7
- 229940039717 lanolin Drugs 0.000 claims description 7
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 6
- 229940032094 squalane Drugs 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 3
- 239000003945 anionic surfactant Substances 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 239000003906 humectant Substances 0.000 claims description 3
- 230000001333 moisturizer Effects 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
- 239000012071 phase Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 10
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000007764 o/w emulsion Substances 0.000 description 5
- 239000003531 protein hydrolysate Substances 0.000 description 5
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000010985 leather Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000013003 healing agent Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940099367 lanolin alcohols Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 231100000435 percutaneous penetration Toxicity 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- -1 polyoxyethylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Peptides Or Proteins (AREA)
- Treatment And Processing Of Natural Fur Or Leather (AREA)
Description
-nya IB'B1? o*oa Taw a*Vnn Oil-in-water skin care emulsion
LUZIER IKCORFORATED
0:28978
This invention relates to stable skin care emulsions. More particularly, it relates to stable
skin care oil-in-water emulsions containing water- soluble polypeptides.
· It has long been recognized that protein
hydrolyzates have a beneficial effect on the skin,
and as a consequence, they have been incorporated in
skin creams and lotions. However, to be useful in
cosmetics of this character, they have to be in a water-. soluble form and ordinarily appear in the aqueous phase of the composition.
It is also known that a number of other
ingredients are advantageously included in skin care
preparations which tend to improve the skin. These
. are exemplified by such materials as mineral oil,
lanolin or acetylated lanolin alcohol, refined wax,
squalane (hexamethyltetracosane), etc. which tend to be hydrophobic in character. Since it is advantageous to add the benefits to the skin contributed by these materials . to the benefits of aqueous solution of protein hydrolyzates, attempts are made to incorporate them in the protein
solutions. This is usually accomplished through the use of an emulsifier which forms an oil-in-water emulsion in which the hydrophobic materials constitute oil phase.
· Although, in theory compositions of the above type (i.e., oil-in-water emulsions containing the protein hydrolyzate in the water phase and the other hydrophobic skin conditioners, moisturizers, etc. in the oil phase)
are very effective, as a matter of fact, there are
severe limitations on these products because of their
* tendency to be unstable. The principal difficulty is that these compositions have been very difficult to
· preserve. This had resulted in the growth of organisms .in the composition which causes a coalescence of the emulsion.
Various attempts have been made to overcome this problem, all of which have left something to be
. desired. Thus, for example, the use of a combination of methyl p- hydroxybenzoate, propyl p-hydroxybenzoate and benzalkanium chloride has been tried. However, these did not lead to a stable system which must also contain an anionic surfactant . Similarly, a combination of methyl . p-hydroxybenzoate, propyl p-hydroxybenzoate and 6-ethoxy- 2,4-dimethyl-in-dioxane has also been tried. This,
however, was unacceptable in that it darkened the products.
Studies also tended to indicate that cosmetic formulations containing water-soluble polypeptides should . be preserved at the lowest possible acceptable pH. This placed a severe limitation on ingredients which could be incorporated in compositions of this character which would tend to raise the pH.
It has now been found that oil-in-water emulsions . containing protein hydrolyzates in the water phase and hydrophobic materials in the oil phase may be very
effectively preserved and thus stabilized by using as a preservative a combination of methyl p-hydroxybenzoate,
propyl p-hydroxybenzoate and sodium ethylmercurithio-salicylate. This system is effective in the presence
of anionic surfactants (e.g., sodium lauryl sulfate).
Furthermore, it is effective in a pH range up to about
8.5 and causes no apparent darkening or oxidation of the product .
It is therefore an object of the present invention to provide a stable oil-in-water emulsion containing water-soluble polypeptides which is stable under the
influence of temperature, time and normal storage conditions.
It is a further object of the present invention to provide a composition set out in the above object
which will serve as a skin care composition capable of enhancing the absorption of water and polypeptide by the skin.
Yet another object of the present invention is to provide a composition of the character set out in
the above objects which is capable of imparting to skin persistent velvet-smooth films.
Other and more detailed objects will be apparent from the following description and claims.
In preparing the skin-care, protein hydrolyzate (i.e., polypeptide) oil-in-water emulsion compositions of the present invention, it is necessary to use a water-soluble polypeptide. Since these materials are water-soluble, the resulting solutions have a viscosity which is substantially identical with water. Any of a variety of water-soluble polypeptides may be used for this purpose. These will usually have a M.V7. in the range of 1500 to 5000.
Of particular interest are those polypeptides which
contain the amino acids ordinarily found in skin. The source of these materials are usually animal skins.
An especially useful polypeptide for the
purpose of the present invention are hydrolysates obtained from tanned leather. These are generally characterized as polypeptides having an average molecular' eight of about 25ΟΟ.
The quantity of polypeptide that will be
used in accordance with the present invention will vary, depending upon the particular type of composition that is desired. In general, however, it will constitute
between .8 to 2 by weight of the total composition, and preferably about 1-5 by weight.
As noted above, the composition of the present invention is an oil-in-water emulsion. The polypeptide, because of its water solubility, and because it is readily transferable to the skin from aqueous solutions, is contained substantially in the aqueous phase.
In addition to the polypeptide described above, it 'is advantageous to include in this composition a
number of materials which are beneficial in skin care.
Thus, for example, it is useful to incorporate therein squalane (i.e., hexamethyltetracosane) . This ingredient acts as a liquid vehicle compatible with skin and sebum. It speeds up percutaneous penetration, accelerates
penetration through the horny layer. It is miscible with sebum and epidermal lipids, and stimulates skin respiration.
The quantity of squalane that may be used in accordance with the present invention may vary somewhat. ,-In general, it will constitute between about 2 to 3 by weight of the total composition, and preferably .5$· · This material is hydrophobic in nature. Accordingly, in the present emulsion it will constitute part of the oil phase of the emulsion.
Allantoin is another material which can
advantageously constitute a component of the present
. invention. It has been found to promote cell-proliferation and remove nectoric tissue. It protects the skin from drying out. and keeps it soft by helping to keep its proper moisture content . Allantoin is proven to be available to the tissues, whether in the form of creams, · lotions, or powders. Also it has been found to have a protein-dispersing (denaturant) effect.
The quantity of allantoin which may be incorporated in the present composition may also be varied depending on the results desired. Ordinarily, it will . constitute between .15$ to - 0$ by weight of the total composition,and preferably .20$. Furthermore, since the allantoin is hydrophilic in character, it will be contained in the aqueous phase of the composition.
In addition to the components mentioned above, · there may be contained in the compositions of this invention the usual additives for skin care preparations . This may include humectants, emollients, moisturizers, fillers, bulking agents, perfumes, emulsifiers, etc.
Furthermore, they may contain medicaments, and particularly medicaments which can help heal minor cuts or wounds.
. The following are illustrations of the various additives which can be incorporated in the present
· invention:
(a) Humectants - glycerine, propylene glycol, sorbitol
polyethyleneglycol .
(b) Emollients - lanolin and its derivatives, e.g.,
acetylated lanolins, ethoxylated
. lanolin alcohols. Patty acid
alcohols and esters .
(c) Emulsifiers - glyceryl monostearate, polyoxyethylene
glycol, sorbitan sesquioleate .
(d) Healing Agents - ethyl aminobenzoate, urea.
· As noted above, an important aspect of the present invention is in the utilization of the combination of methyl p-hydroxybenzoate, propyl p-hydroxybenzoate, and sodium ethylmercurithiosalicylate as a preservative system. The quantity of the respective materials may vary somewhat. . However, the usual quantities that may be employed and the preferred quantities are set out in the table below. The percent by weight indicated below is on the basis of the total composition.
Range Preferred
j> by Wt. $> by t. methyl-p-hydroxybenzoate .08 to .2 .1
propyl-p-hydroxybenzoate .03 to .1 .05 sodium ethylmercurithiosalicylate .01 to .03 .02
Ordinarily, the propyl-p-hydroxybenzoate will be contained in the oil phase of the present emulsion composition.
The methyl-p-hydroxybenzoate and the sodium ethylmercuri-thiosalicylate will comprise a portion or portions of
the aqueous phase.
As noted above, the pH of the present composition can have a value up to about 8.5 · However, ordinarily, it will be in the range of about 6.5 to 8.5, and preferably in creams having a value of about 6.8 and in lotions
having a value of about 8.2.
The following examples are further illustrative of the present invention. It should be understood, however, that the invention is not limited thereto.
EXAMPLE 1
A stable cosmetic cream is prepared as oil-in-water emulsion having the following composition, having a pH of 6.5-7Ό.
OIL PHASE
COMPONENT PERCENT BY WEIGHT
Viscosity 50-55 ) 10.0
Acetulan* 4.0
Stearic acid 4.0
Cetyl alcohol 2.0
Refined paraffin wax .0
Lanolin (odorless) 3.O
Squalane 3.O
Propyl p-hydroxybenzoate 0.05
Acetylated lanolin fraction. Pale yellow liquid d. 0.867; neutral reaction; acid No. Ο.36; saponification No. 190.3.
AQUEOUS PHASE
COMPONENT PERCENT BY WEIGHT
Glycerin 2.0
Borax 0.5
Triethanolamine 0.7
Polypeptide LSN (water soluble)* C aq. 4.0
Methyl p-hydroxybenzoate 0.1
Sodium ethylmercurithiosalicylate * 0.02
Allantoin 0.20
Distilled water q.s.lOO
Components of the oil phase are melted together to l80°F. Components of the aqueous phase are dissolved by heating to l85°F. The oil phase is then added to the aqueous phase with mild mixing to room temperature.
EXAMPLE II
A stable cosmetic lotion prepared from the following components having a pH of 8.0 - 8.5·
OIL PHASE
COMPONENT PERCENT BY WEIGHT
Glyceryl monostearate 2.7
Cetyl alcohol 1.5
Acetulan 2.0
Squalane 3 · 0
Propyl p-hydroxybenzoate 0.05
Polypeptide, LSN: A water-soluble polypeptide having an average M.W. of about 2500 obtained from the
partial hydrolysis of tanned leather.
AQUEOUS PHASE
COMPONENT PERCENT BY WEIGHT
Polypeptide LSN (water soluble) 0 aq. 2.0
Sodium lauryl sulfate (USP Powder) 0.3
Methyl p-hydroxybenzoate 0.1
Sodium ethylmercurithiosalicylate 0.02
Allantoin ' 0.2
Distilled water q.s. 100
The oil phase is added to the aqueous phase as explained in Example I. Allantoin is dissolved in ten parts by weight of water, then added after the emulsion is formed.
In this stable formulation, 0.3 percent by weight of sodium lauryl sulfate (anionic) was incorporated to find out whether the product can be stable in the presence of anionic detergent. Also, in this stable formulation, 2.0 percent by weight of Acetulan was
incorporated in the cream to give the skin a velvet-smooth protective film. Also incorporated as a medicinal ingredient was 0.2 percent by weight of Allantoin. The emulsion was tested at 115°F^ temperature and freezing temperature for a period of 365 days. No rancidity, discoloration, or separation was observed.
Although the invention has been described with reference to specific forms thereof, it will be understood that many changes and modifications may be made without departing from the spirit of this invention.
Claims (7)
1. Improved oil-in-water stable composition for skin care containing a water-soluble polypeptide e£-h«A e-aJL ' ~ , - 1 s 'UCt'u'g-and— oOTTb¾-lning' amino- -oxid-& ordinarily found in animal skins, in the aqueous phase, the improvement charac- terized by the fact that the composition contains a stabiliz- ing amount of a preservative system comprising methyl-p- hydroxybenzoate, propyl-p-hydroxybenzoate and sodium ethyl- mercurithiosalicylate substantially in the amounts, by weight of the total composition: (a) .08 to ,20% methyl-p-hydroxybenzoate, (b) .03 to .10$ propyl-p-hydroxybenzoate, and (c) .01 to .03$ sodium ethylmercurithiosalioylate.
2. An improved composition according to claim 1, the • ί improvement characterized by including from .15 to . 0$ by weight of allantoin and from 2% to 3$ by weight of squalane.
3· An improved composition according to olaim 2, the improvement characterized by the fact that the pH is in the range of from 6.5 to 8.5.
» A improved composition acoordlng to claims 1 to 3* the improvement characterized by including an anionic surfactant.
5· An improved composition according to'olaim the improvement characterized by including an emollient, a moisturizer and a humectant.
6* An improved composition according to claim 5» the improvement characterized by containing a material selected from the group consisting of lanolin and acetylated. lanolin 3070/ 2 alcohol.
7. An improved composition according to claim 6, the improvement characterized by the fact that the polypeptide has a molecular weight in the range of from about ISOO to 5000.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68034967A | 1967-11-03 | 1967-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL30741A0 IL30741A0 (en) | 1968-11-27 |
| IL30741A true IL30741A (en) | 1972-06-28 |
Family
ID=24730733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL30741A IL30741A (en) | 1967-11-03 | 1968-09-19 | Oil-in-water skin care emulsion |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS4814931B1 (en) |
| AT (1) | AT286502B (en) |
| BE (1) | BE720891A (en) |
| CH (1) | CH494030A (en) |
| CS (1) | CS159235B2 (en) |
| DE (1) | DE1801840A1 (en) |
| DK (1) | DK122788B (en) |
| ES (1) | ES358959A1 (en) |
| FR (1) | FR1594624A (en) |
| GB (1) | GB1202635A (en) |
| IE (1) | IE32342B1 (en) |
| IL (1) | IL30741A (en) |
| IT (1) | IT975508B (en) |
| NL (1) | NL6815169A (en) |
| SE (1) | SE348367B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5564512A (en) * | 1978-11-11 | 1980-05-15 | Kanebo Ltd | Cosmetic composition of oil-in-water emulsion |
| FR2478467A1 (en) * | 1980-03-21 | 1981-09-25 | Fabre Sa Pierre | NOVEL COMPOSITIONS USEFUL IN THE TREATMENT AND PREVENTION OF FILM AND CONTAINING METAL DERIVATIVES OF THIOBENZOIC ACID |
| JPS62158541U (en) * | 1986-03-27 | 1987-10-08 | ||
| ATE201585T1 (en) * | 1998-02-12 | 2001-06-15 | Oreal | USE OF 1,2-PENTANEDIOL IN A COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING FILM-FORMING POLYMER PARTICLES IN AQUEOUS DISPERSION AND COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING THE ABOVE INGREDIENTS |
| US20020054895A1 (en) | 1999-07-23 | 2002-05-09 | Alwyn Company, Inc. | Allantoin-containing skin cream |
| US6864274B2 (en) * | 1999-07-23 | 2005-03-08 | Alwyn Company, Inc. | Allantoin-containing skin cream |
| US6281236B1 (en) * | 1999-07-23 | 2001-08-28 | Alwyn Company, Inc. | Oil-in-water emulsion with improved stability |
| FR2804862B1 (en) * | 2000-02-10 | 2002-06-07 | Fabre Pierre Dermo Cosmetique | COSMETIC COMPOSITIONS BASED ON THIOSALICYL DERIVATIVES AND NOVEL THINOSALICYL DERIVATIVES OF THE QUINOLYL TYPE |
| EP1284601A4 (en) * | 2000-05-12 | 2005-02-09 | Alwyn Co Inc | Allantoin-containing skin cream |
| US20140135372A1 (en) | 2010-02-02 | 2014-05-15 | Elliott Farber | Compositions and methods of treatment of inflammatory skin conditions using allantoin |
| CN119344461B (en) * | 2024-10-31 | 2025-08-12 | 南昌大学 | A kind of oil-loaded polypeptide low-water emulsion and its preparation method and application |
-
1968
- 1968-09-16 BE BE720891D patent/BE720891A/xx unknown
- 1968-09-19 IL IL30741A patent/IL30741A/en unknown
- 1968-09-30 IE IE1169/68A patent/IE32342B1/en unknown
- 1968-10-03 GB GB47070/68A patent/GB1202635A/en not_active Expired
- 1968-10-03 FR FR1594624D patent/FR1594624A/fr not_active Expired
- 1968-10-04 CH CH1483868A patent/CH494030A/en not_active IP Right Cessation
- 1968-10-08 ES ES358959A patent/ES358959A1/en not_active Expired
- 1968-10-08 DE DE19681801840 patent/DE1801840A1/en active Pending
- 1968-10-15 JP JP43074727A patent/JPS4814931B1/ja active Pending
- 1968-10-17 AT AT1016868A patent/AT286502B/en not_active IP Right Cessation
- 1968-10-21 SE SE14161/68A patent/SE348367B/xx unknown
- 1968-10-23 NL NL6815169A patent/NL6815169A/xx unknown
- 1968-10-25 IT IT40718/68A patent/IT975508B/en active
- 1968-10-25 DK DK517168AA patent/DK122788B/en unknown
- 1968-10-29 CS CS738168A patent/CS159235B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1801840A1 (en) | 1969-06-12 |
| NL6815169A (en) | 1969-05-06 |
| BE720891A (en) | 1969-03-17 |
| JPS4814931B1 (en) | 1973-05-11 |
| DK122788B (en) | 1972-04-17 |
| IE32342B1 (en) | 1973-06-27 |
| ES358959A1 (en) | 1970-05-16 |
| AT286502B (en) | 1970-12-10 |
| GB1202635A (en) | 1970-08-19 |
| FR1594624A (en) | 1970-06-08 |
| CS159235B2 (en) | 1974-12-27 |
| IL30741A0 (en) | 1968-11-27 |
| IT975508B (en) | 1974-08-10 |
| IE32342L (en) | 1969-05-03 |
| CH494030A (en) | 1970-07-31 |
| SE348367B (en) | 1972-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5153230A (en) | Topical skin cream composition | |
| US6001341A (en) | Deodorant and/or antiperspirant cosmetic compositions | |
| US4883659A (en) | Skin treatment preparation | |
| JP3532244B2 (en) | Mucopolysaccharide fragmentation inhibitor, active oxygen scavenger and cosmetic | |
| US4545990A (en) | Anti-acne composition | |
| JP3037145B2 (en) | Silicone composition containing water-reactive activator | |
| US5039516A (en) | Sunscreen preparation | |
| US5599800A (en) | Organopolysiloxane composition of gel-like appearance, containing no gelling agent, which may be used in cosmetics and dermatology | |
| EP0047804A1 (en) | Water-in-oil emulsions and process for preparing same | |
| JP2000229832A (en) | Skin lotion | |
| IL30741A (en) | Oil-in-water skin care emulsion | |
| US20070172440A1 (en) | Transparent cosmetic microemulsion-based formulation containing an alpha-hydroxy-carboxylic acid | |
| EP0218441B1 (en) | Cosmetic composition | |
| JPH05221821A (en) | Skin-care cosmetic | |
| JP2983311B2 (en) | External preparation for skin | |
| JPH07206645A (en) | Hair growth agent and cosmetic for hair of head containing the same | |
| EP0014509A2 (en) | Skin conditioning compositions | |
| JP2549119B2 (en) | Topical | |
| JPS6231975B2 (en) | ||
| JP2836772B2 (en) | Cosmetics | |
| JPH04321615A (en) | Skin medicine for external use | |
| IL91422A (en) | Stable oil and water emulsion and thin films and cosmetics therefrom | |
| JPH0892062A (en) | Topical | |
| JP3093353B2 (en) | External preparation for skin | |
| JPH01100113A (en) | External preparation for skin |